Vectus Biosystems (ASX:VBS) Price-to-Tangible-Book : 5.00 (As of Jun. 20, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Price-to-Tangible-Book?

As of today (2025-06-20), Vectus Biosystems's share price is A$0.04. Vectus Biosystems's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was A$0.01. Hence, Vectus Biosystems's Price to Tangible Book Ratio of today is 5.00.

The historical rank and industry rank for Vectus Biosystems's Price-to-Tangible-Book or its related term are showing as below:

ASX:VBS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.75 Med: 8.13 Max: 280
Current: 4

During the past 9 years, Vectus Biosystems's highest Price to Tangible Book Ratio was 280.00. The lowest was 2.75. And the median was 8.13.

ASX:VBS's Price-to-Tangible-Book is ranked worse than
64.67% of 1200 companies
in the Biotechnology industry
Industry Median: 2.84 vs ASX:VBS: 4.00

A closely related ratio is called PB Ratio. As of today, Vectus Biosystems's share price is A$0.04. Vectus Biosystems's Book Value per Sharefor the quarter that ended in Dec. 2024 was A$0.01. Hence, Vectus Biosystems's P/B Ratio of today is 5.00.

Vectus Biosystems Price-to-Tangible-Book Historical Data

The historical data trend for Vectus Biosystems's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Price-to-Tangible-Book Chart

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.67

2.75

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial													8.02	6.67	6.67	2.75	9.63

Competitive Comparison of Vectus Biosystems's Price-to-Tangible-Book

For the Biotechnology subindustry, Vectus Biosystems's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Vectus Biosystems Price-to-Tangible-Book Calculation

Vectus Biosystems's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	0.04	/	0.008
	=	5.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Vectus Biosystems Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018

Website

https://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.

Vectus Biosystems Headlines

No Headlines